Lumacaftor/Ivacaftor Combination Therapy in Subjects With CF Who Have an A455E CFTR Mutation
Clinical trial NCT03061331 · COMPLETED
Trial details
- NCT number
- NCT03061331
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-31
- Primary completion
- 2017-09-06
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.